Key result
Diltiazem resolves acetylcholine-provoked vasospastic angina and ventricular fibrillation in Fabry disease.
Why the study?
In Fabry disease, life-threatening arrhythmias are a major cause of cardiac death and are typically related to myocardial fibrosis assessed by late gadolinium enhancement, leaving the mechanism of ventricular fibrillation in patients without late gadolinium enhancement less clear.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
Alerts clinicians to possible spasm-VF link in Fabry disease; hypothesis-generating and should not yet alter practice.
BACKGROUND: Fabry disease (FD) is an X-linked lysosomal storage disorder resulting from a deficiency in alpha-galactosidase A. The major causes of death due to cardiac complications include life-threatening arrhythmias. In addition, life-threatening arrhythmias may be related to myocardial fibrosis assessed by late gadolinium enhancement (LGE). CASE SUMMARY: A 43-year-old man with sinus bradycardia and left ventricular hypertrophy was referred to our cardiology department. Family history includes unexplained hypertrophy and sick sinus syndrome in mother. Additionally, his plasma alpha-galactosidase A activity was low. He was subsequently diagnosed with FD. Enzyme replacement therapy using 1.0 mg/kg agalsidase-β was initiated. During the fifth administration, he developed ventricular fibrillation (VF). Electrocardiography conducted immediately before VF revealed ST elevation in the inferior leads with reciprocated ST depression. Cardiac magnetic resonance imaging showed no LGE in the myocardium. Coronary angiography showed no organic stenosis; moreover, coronary spasms were induced by an intracoronary acetylcholine injection. Ventricular fibrillation was not observed as the patient received calcium antagonists. DISCUSSION: This report suggests that vasospastic angina pectoris is associated with life-threatening arrhythmias in patient with FD without LGE.
No takes yet. Share an insight, caveat, or question.
Kodama et al. (2019) conducted a case report in Fabry disease with vasospastic angina pectoris and ventricular fibrillation (n=1). Vasospastic angina pectoris managed with diltiazem was evaluated on Ventricular fibrillation recurrence. Vasospastic angina pectoris provoked by intracoronary acetylcholine (50-) was associated with ventricular fibrillation in a 43-year-old man with Fabry disease and resolved with diltiazem.
Synapse has enriched 10 related papers. Consider them for comparative context: